SeDeM expert system with I-optimal mixture design for oral multiparticulate drug delivery: An encapsulated floating minitablets of loxoprofen Na and its in silico physiologically based pharmacokinetic modeling

被引:1
作者
Rauf-ur-Rehman [1 ]
Shoaib, Muhammad Harris [1 ]
Ahmed, Farrukh Rafiq [1 ]
Yousuf, Rabia Ismail [1 ]
Siddiqui, Fahad [1 ]
Saleem, Muhammad Talha [1 ]
Qazi, Faaiza [1 ]
Khan, Momina Zarish [1 ]
Irshad, Asma [1 ]
Bashir, Lubna [2 ]
Naz, Shazia [2 ]
Farooq, Muhammad [1 ]
Mahmood, Zafar Alam [1 ]
机构
[1] Univ Karachi, Fac Pharm & Pharmaceut Sci, Dept Pharmaceut, Karachi, Sindh, Pakistan
[2] Fed Urdu Univ Arts Sci & Technol, Fac Pharm, Dept Pharmaceut, Karachi, Pakistan
关键词
multiparticulate drug delivery system; SeDeM expert tool; loxoprofen Na; in silico PBPK; extended release minitablets; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTRORETENTIVE DOSAGE FORMS; MINI-TABLETS; RELEASE; VITRO; BIOAVAILABILITY;
D O I
10.3389/fphar.2023.1066018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: A SeDeM expert tool-driven I-optimal mixture design has been used to develop a directly compressible multiparticulate based extended release minitablets for gastro-retentive drug delivery systems using loxoprofen sodium as a model drug.Methods: Powder blends were subjected to stress drug-excipient compatibility studies using FTIR, thermogravimetric analysis, and DSC. SeDeM diagram expert tool was utilized to assess the suitability of the drug and excipients for direct compression. The formulations were designed using an I-optimal mixture design with proportions of methocel K100M, ethocel 10P and NaHCO3 as variables. Powder was compressed into minitablets and encapsulated. After physicochemical evaluation lag-time, floating time, and drug release were studied. Heckel analysis for yield pressure and accelerated stability studies were performed as per ICH guidelines. The in silico PBPK Advanced Compartmental and Transit model of GastroPlus (TM) was used for predicting in vivo pharmacokinetic parameters.Results: Drug release follows first-order kinetics with fickian diffusion as the main mechanism for most of the formulations; however, a few formulations followed anomalous transport as the mechanism of drug release. The in-silico-based pharmacokinetic revealed relative bioavailability of 97.0%.Discussion: SeDeM expert system effectively used in QbD based development of encapsulated multiparticulates for once daily administration of loxoprofen sodium having predictable in-vivo bioavailability.
引用
收藏
页数:18
相关论文
共 63 条
[1]   Pharmacokinetics of loxoprofen in a self-administered overdose in a Japanese patient admitted to hospital [J].
Adachi, Koichiro ;
Sugitani, Yuki ;
Unita, Ryo ;
Yoshida, Kosuke ;
Beppu, Satoru ;
Terashima, Mariko ;
Fujii, Masaya ;
Shimizu, Makiko ;
Yamazaki, Hiroshi .
JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2021, 7 (01)
[2]   Clay nanotubes as a novel multifunctional excipient for the development of directly compressible diclofenac potassium tablets in a SeDeM driven QbD environment [J].
Ahmed, Farrukh Rafiq ;
Shoaib, Muhammad Harris ;
Yousuf, Rabia Ismail ;
Ali, Tariq ;
Geckeler, Kurt E. ;
Siddiqui, Fahad ;
Ahmed, Kamran ;
Qazi, Faaiza .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 133 :214-227
[3]  
Ajay B., 2010, INT J COMPREN PHARMA, V5, P1
[4]   Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups [J].
Aleksovski, Aleksandar ;
Dreu, Rok ;
Gasperlin, Mirjana ;
Planinsek, Odon .
EXPERT OPINION ON DRUG DELIVERY, 2015, 12 (01) :65-84
[5]   Physicochemical characterization and compatibility study of roflumilast with various pharmaceutical excipients [J].
Ali, Faraat ;
Kumar, Robin ;
Sahu, Puran Lal ;
Singh, Gyanendra Nath .
JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2017, 130 (03) :1627-1641
[6]   Floating drug delivery systems: A review [J].
Arora, S ;
Ali, J ;
Ahuja, A ;
Khar, RK ;
Baboota, S .
AAPS PHARMSCITECH, 2005, 6 (03) :E372-E390
[7]   Gastroretentive dosage forms:: Overview and special case of Helicobacter pylori [J].
Bardonnet, PL ;
Faivre, V ;
Pugh, WJ ;
Piffaretti, JC ;
Falson, F .
JOURNAL OF CONTROLLED RELEASE, 2006, 111 (1-2) :1-18
[8]  
Campiez M.D., 2016, Int. J. Clin. Pharmacol. Pharmacother, V1, P105, DOI [10.15344/2456-3501/2016/105, DOI 10.15344/2456-3501/2016/105]
[9]  
Carstensen J. T., 1993, PHARM PRINCIPLES SOL, P15
[10]  
Cavalcanti Osvaldo Albuquerque, 2004, Acta Farmaceutica Bonaerense, V23, P53